Intracerebral transplantation of neural stem cells (NSCs)
for ischemic
stroke treatment has been demonstrated to be inefficient, with only
<5% of delivered cells being retained. Microcapsules may be a good
carrier for NSC delivery; however, the current microcapsules do not
fully meet the demands for cell survival after transplantation. In
the present study, we designed a strategy for the encapsulation of
NSCs in a novel lipid-alginate (L-A) microcapsule based on a two-step
method. The protective effect of a L-A microcapsule on oxygen-glucose
deprivation (OGD) was investigated by using the CCK8 test, the LDH
release test, and flow cytometry. Mechanisms underlying the prosurvival
effect were investigated by detecting autophagy markers like P62,
LC3-I, and LC3-II, and autophagy flux analysis was also performed.
Lastly, the ability of the L-A microcapsule to support NSCs delivery
for ischemic stroke was investigated in the middle cerebral artery
occlusion (MCAO) model. We found that L-A microcapsules exerted a
good protective effect against OGD compared with control and alginate
microcapsules. The L-A microcapsules were found to promote cell survival
by not only providing a “physical” barrier but also
altering autophagy markers like P62 and LC3-II, which enhanced autophagy
flux. This novel microcapsule was confirmed to be suitable for NSC
delivery in vivo, which alleviated transplanted NSC apoptosis, reduced
the infarct volume, decreased brain edema, improved neurological deficit
scores, and lastly, improved survival rate. The findings of this study
may provide a new method for stem cell delivery, raising the prospect
that intracerebral cell transplantation may be used to treat, for
instance, ischemic stroke, traumatic brain injury, and so on.